These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30276131)

  • 1. A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals.
    Kumar A; Kumar S; Nanda A
    Adv Pharm Bull; 2018 Aug; 8(3):355-363. PubMed ID: 30276131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Patents of Pharmaceutical Co-Crystals: Product Development on Anti-Cancer Drugs and Beyond.
    Tharik AAMS; Meyyanathan SN
    Recent Pat Anticancer Drug Discov; 2023; 18(3):246-267. PubMed ID: 36100994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Co-Crystallization: Regulatory Aspects, Design, Characterization, and Applications.
    Raheem Thayyil A; Juturu T; Nayak S; Kamath S
    Adv Pharm Bull; 2020 Jun; 10(2):203-212. PubMed ID: 32373488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Crystals for Generic Pharmaceuticals: An Outlook on Solid Oral Dosage Formulations.
    Rajendran MAP; Allada R; Sajid SS
    Recent Adv Drug Deliv Formul; 2021; 15(1):15-36. PubMed ID: 34602030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicomponent crystal compromising dasatinib and selected co-crystals formers: a patent evaluation of EP2861589B1.
    Rathi R; Singh I
    Pharm Pat Anal; 2022 Jan; 11(1):15-21. PubMed ID: 35172634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocrystallization: Cutting Edge Tool for Physicochemical Modulation of Active Pharmaceutical Ingredients.
    Kumari N; Ghosh A
    Curr Pharm Des; 2020; 26(38):4858-4882. PubMed ID: 32691702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.
    Almarsson Ö; Peterson ML; Zaworotko M
    Pharm Pat Anal; 2012 Jul; 1(3):313-27. PubMed ID: 24236844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug co-crystals: towards the development of effective therapeutic hybrids.
    Thipparaboina R; Kumar D; Chavan RB; Shastri NR
    Drug Discov Today; 2016 Mar; 21(3):481-90. PubMed ID: 26869329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior Dissolution Behavior and Bioavailability of Pharmaceutical Cocrystals and Recent Regulatory Issues.
    Xia MY; Zhu BQ; Wang JR; Yang ZE; Mei XF
    ACS Med Chem Lett; 2022 Jan; 13(1):29-37. PubMed ID: 35059121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical cocrystals: walking the talk.
    Bolla G; Nangia A
    Chem Commun (Camb); 2016 Jun; 52(54):8342-60. PubMed ID: 27278109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?
    Dalpiaz A; Pavan B; Ferretti V
    Drug Discov Today; 2017 Aug; 22(8):1134-1138. PubMed ID: 28130117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced methodologies for cocrystal synthesis.
    Douroumis D; Ross SA; Nokhodchi A
    Adv Drug Deliv Rev; 2017 Aug; 117():178-195. PubMed ID: 28712924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solvent-free Methods for Co-crystal Synthesis: A Review.
    Kumar S; Prakash O; Gupta A; Singh S
    Curr Org Synth; 2019; 16(3):385-397. PubMed ID: 31984900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently?
    Ferretti V; Dalpiaz A; Bertolasi V; Ferraro L; Beggiato S; Spizzo F; Spisni E; Pavan B
    Mol Pharm; 2015 May; 12(5):1501-11. PubMed ID: 25794305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies.
    Ross SA; Lamprou DA; Douroumis D
    Chem Commun (Camb); 2016 Jul; 52(57):8772-86. PubMed ID: 27302311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical cocrystals: along the path to improved medicines.
    Duggirala NK; Perry ML; Almarsson Ö; Zaworotko MJ
    Chem Commun (Camb); 2016 Jan; 52(4):640-55. PubMed ID: 26565650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design.
    Berry DJ; Steed JW
    Adv Drug Deliv Rev; 2017 Aug; 117():3-24. PubMed ID: 28344021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanochemical preparation of co-crystals.
    Braga D; Maini L; Grepioni F
    Chem Soc Rev; 2013 Sep; 42(18):7638-48. PubMed ID: 23549606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.
    Yadav AV; Shete AS; Dabke AP; Kulkarni PV; Sakhare SS
    Indian J Pharm Sci; 2009 Jul; 71(4):359-70. PubMed ID: 20502540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy and Methodology in the Synthesis of Multicomponent Molecular Solids: The Quest for Higher Cocrystals.
    Mir NA; Dubey R; Desiraju GR
    Acc Chem Res; 2019 Aug; 52(8):2210-2220. PubMed ID: 31318527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.